ArticlePain2026
A nociceptor excitability test for identifying alterations of the Nav1.7 channels in humans.
Article in Pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
abstractSodium channel variants are associated with small fiber neuropathy. While in vitro recordings allow detailed assessment of sodium channel function, their contribution to peripheral small nerve fiber excitability remains unstudied. The perception threshold tracking (PTT) method allows indirect assessment of small fiber function by transcutaneous electrical stimulation and psychophysics. Here, we developed a Sodium channel Excitability Nociceptor Test that allows for the identification of alterations in selected subtypes of sodium channels in small fibers of awake humans. We hypothesize that due to the unique dynamics of sodium channels, it is possible to derive a nerve excitability test to uniquely identify alterations in the Na v 1.7 channel. Using a multicompartmental nerve fiber model, a set of 5 electrical pulse shapes was developed. These pulse shapes consist of rectangular and ramp test pulses preceded by either a hyperpolarizing or depolarizing prepulse. To validate the predictive power of our in silico simulations, we used an automated whole-cell patch clamp on Na v 1.7 expressed in HEK293T cells and a PTT experiment in healthy participants. The computational model predicted that an alteration of Na v 1.7 can be classified with an accuracy of 92% (n = 30) when the standard deviation of the perception threshold is 11%, which was measured by the PTT experiment. The peak Na v 1.7 current elicited in vitro corresponded well with the prediction of the in silico model. The study thus provides an excitability test to predict the involvement of Na v 1.7, and potentially also Na v 1.8 and Na v 1.9, in the generation of neuropathic pain in small fiber neuropathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.